prof. dr. Jo Lambert
- ORCID iD
- 0000-0001-5303-9310
Show
Sort by
-
- Journal Article
- A1
- open access
Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort
-
- Journal Article
- A1
- open access
Value in psoriasis (IRIS) trial : implementing value-based healthcare in psoriasis management : a 1-year prospective clinical study to evaluate feasibility and value creation
-
- Journal Article
- A1
- open access
PsoPlus : an integrated practice unit for psoriasis
-
- Journal Article
- A1
- open access
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study
-
- Journal Article
- A1
- open access
Initiating value‐based healthcare in psoriasis : proposing a value‐based outcome set for daily clinical practice
-
- Journal Article
- A1
- open access
Determining patient value profiles in psoriasis
-
Therapeutic drug monitoring of biologics in inflammatory bowel disease : unmet needs and future perspectives
-
Credibility and generalization of the minimally important difference concept in dermatology : a scoping review
-
- Journal Article
- A1
- open access
Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis
-
Defining value for patients with psoriasis : development of a patient-driven outcome set for clinical practice
-
The effects of Modified Intermittent Fasting in Psoriasis (MANGO) : preliminary results of a pilot crossover study
-
- Journal Article
- A1
- open access
Freedom from disease in psoriasis : a Delphi consensus definition by patients, nurses and physicians
-
Weighing in on weight‐based secukinumab dosing for psoriasis
-
- Journal Article
- A1
- open access
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic : findings from a global patient-reported cross-sectional survey
-
International eDelphi study to reach consensus on the methotrexate dosing regimen in patients with psoriasis
-
- Journal Article
- A1
- open access
Real-life effectiveness of apremilast for the treatment of psoriasis in Belgium : results from the observational OTELO study
-
- Journal Article
- A1
- open access
Variability drivers of treatment costs in hospitals : a systematic review
-
- Journal Article
- A2
- open access
The effects of Modified Intermittent Fasting in Psoriasis (MANGO) trial : a two-arm pilot randomized controlled open cross-over study
-
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey
-
- Journal Article
- A1
- open access
Promising tools to facilitate the implementation of TDM of biologics in clinical practice
-
Patient-relevant outcomes in psoriasis : a systematic review
-
- Journal Article
- A1
- open access
Adalimumab with methotrexate vs. adalimumab monotherapy in psoriasis : first-year results of a single-blind randomized controlled trial
-
- Journal Article
- A1
- open access
Long‐term efficacy and safety of brodalumab in moderate‐to‐severe plaque psoriasis : a post hoc pooled analysis of AMAGINE‐2 and ‐3
-
- Journal Article
- A2
- open access
Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study
-
- Journal Article
- A1
- open access
Venous thrombotic events in psoriasis patients : a systematic review with meta-analysis
-
Creating value for psoriasis patients : development of a patient-driven outcome set for clinical practice
(2021) JOURNAL OF INVESTIGATIVE DERMATOLOGY. In Journal of Investigative Dermatology 141(10). p.S160-S160 -
Interim results of the MANGO trial : modified intermittent fasting in psoriasis
(2021) JOURNAL OF INVESTIGATIVE DERMATOLOGY. In Journal of Investigative Dermatology 141(10). p.S190-S190 -
Comment on 'An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology'
-
- Journal Article
- A1
- open access
Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type : a cross‐sectional patient survey
-
- Journal Article
- A1
- open access
Cutaneous manifestations in biological-treated inflammatory bowel disease patients : a narrative review
-
- Journal Article
- A1
- open access
Dermatology life quality index in patients with moderate-to-severe plaque psoriasis treated with Brodalumab or Ustekinumab
-
Describing the burden of the COVID‐19 pandemic in people with psoriasis : findings from a global cross‐sectional study
-
- Journal Article
- A1
- open access
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis : study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study : the BeNeBio study
-
Factors associated with adverse COVID-19 outcomes in patients with psoriasis : insights from a global registry–based study
-
- Journal Article
- A1
- open access
Personalized development of antisense oligonucleotides for exon skipping restores type XVII collagen expression in junctional epidermolysis bullosa
-
Alopecia areata : a review on diagnosis, immunological etiopathogenesis and treatment options
-
- Journal Article
- A2
- open access
The use of metrics in daily practice and the perception of psoriasis-associated comorbidities : discrepancies between research and real-world
-
The reliability of the Self-Assessment Cutaneous Inflammatory Disease Extent Score (SA-CIDES) and the rule of hands to assess the involved body surface area in psoriasis and eczema
-
- Journal Article
- A1
- open access
Vaccinations in patients receiving systemic drugs for skin disorders : what can we learn for SARS-Cov-2 vaccination strategies?
-
- Journal Article
- A1
- open access
The implementation of a structured specialized consultation for psoriasis management
-
First results of the BELCOMID study : Belgian cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)
-
Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis : a Belgian retrospective multicentre study
-
- Journal Article
- A1
- open access
Autoimmunity in segmental vitiligo
-
- Journal Article
- A1
- open access
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1)
-
- Journal Article
- A1
- open access
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2)
-
- Journal Article
- A1
- open access
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
-
- Journal Article
- A1
- open access
Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis
-
- Journal Article
- A1
- open access
Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials
-
Teledermatology in Belgium : a pilot study
-
- Journal Article
- A1
- open access
A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents